Conference Agenda

Wednesday, April 26, 2017

8:00am - 9:30am — Breakfast / Registration / Exhibits Open
8:30 - 9:30am — PitchRounds #1

PitchRound companies meet with investors and potential partners to make deals!

9:30am - 10:00am — Welcoming Remarks

Opening Remarks

State of SEMDA and the Medtech Industry in the Southeast.

Jason Rupp
Executive Director, SEMDA

10:00 - 11:00am — Opening Keynote: Aimee Copeland

Aimee Copeland

In May 2012, Aimee Copeland was a typical 24 year old earning her Master’s degree in psychology when she and friends took an afternoon off to enjoy the sun at a nearby river. They found a homemade zip line that made the day even more enjoyable, until on Aimee’s second run the line snapped. Aimee fell into the rocks below, leaving her with a deep gash in her left calf.

A trip to the hospital and some 22 surgical staples later she was home, but it wasn’t the end of Aimee’s saga. After three days she was rushed to the hospital and it was determined that she had necrotizing fasciitis, a rare flesh-eating bacteria that took nearly took her life and did take both her arms below the elbow, her right leg below the knee, and nearly her entire left leg.

Aimee will share her story and the provide a personal account of the value of medtech innovation.

11:00am - 11:15am — Networking Break
11:15am - 12:15pm — Concurrent Session #1

Concurrent Session 1A

Immigration & Compliance for Employers: Practical Advice for Uncertain Times

Concurrent Session 1B

More information soon

12:15pm - 1:30pm — Lunch Keynote Panel: The Politics of Innovation

How does the political landscape influence investment in innovation in the US medtech industry?  How has the role of government in the development of new innovative medical devices evolved in recent years?  What should the medtech industry be anticipating during this new administration transition period?  This panel will provide insight on federal policies, processes, programs that support innovation and entrepreneurship in the medtech sector, as well as advice on working with government and political leaders to accelerate industry growth.

Craig Buerstatte
Acting Director, Office of Innovation & Entrepreneurship
US Department of Commerce, EDA

Russ Lipari
Founder & CEO
Health Connect South

Ashley Wittorf
Executive Director & Sr. Vice President
AdvaMed Accel

Tiffany Wilson (Moderator)
CEO
GCMI & T3 Labs

1:30pm - 1:45pm — Break
1:45pm - 2:45pm — Concurrent Session #2

Concurrent Session #2A:

Data Breach Risks – Updates for the Medical Device Industry

Concurrent Session #2B:

Funding 20/20

2:45pm - 3:45pm — Concurrent Sessions #3

Concurrent Session #3A:

IP and M&A

Concurrent Session #3B:

Beyond the press release: Integrated marketing strategies for medtech and med device

Effective B2B healthcare marketers know press releases don’t move the meter for most growth stage medtech and med device companies. Great stories do. How do you find, produce and distribute stories that make metrics driven marketing programs sing? Attendees will learn from each level of the organization, from the CEO through scientific program directors responsible for supporting business development and marketing. We will discuss the why, who and how to build strategic, integrated, value-based marketing programs that drive measurable results even with limited internal teams and compliance constraints.

Lori Chmura
CEO, Dune Medical Devices

Michael Krachon 
Vice President of Sales & Marketing, Isoray

Deepal Panchal 
Program Director, GCMI and T3 Labs

Paul Snyder
VP Healthcare, Write2Market – moderator

3:45pm - 4:15pm — Networking Break

Announce Pitch Company finalists and mentors

4:15pm - 5:15pm — Concurrent Sessions #4

Concurrent Session #4A:

Innovation: Hype or Reality?

Concurrent Session #4B:

Innovative Business Models

5:15pm - 6:15pm — Poster Session & PitchRounds Elevator Pitches

Poster Sessions will highlight emerging technologies from Universities around the region.

PitchRounds Elevator Pitches will provide our PitchRound companies three minutes to share their story and

6:30pm - 8:00pm — Gala Reception / Spotlight Award Presentation

Pitch finalists will be announced.

Thursday, April 27, 2017

8:00am - 9:15am — Breakfast / Registration / Exhibits Open
8:30 - 9:15am — PitchRounds #3
9:00am - 10:00am — Breakfast Keynote: Don Turner, IBM Watson Health

Don Turner, Global Head, Commercialization, IBM Watson Health

Don Turner has more than two decades of experience commercializing transformative and award winning solutions across numerous industry verticals on a global basis. Don has served in roles such as Chairman of the Board, CEO, COO, and CTO for globally recognized companies, served on the advisory board for Cisco Systems, committee chairman for Massachusetts Biotechnology Council, advisory board member and program director for the new technologies ventures group at Northrup Grumman, lectured at business schools on commercialization and entrepreneurship, spoken at industry conferences on personalized medicine, served on healthcare innovation and investment panels, chaired steering committees, and worked pro bono for several years as a shadow CXO for growth stage companies as a means of giving back.

10:00 - 10:15am — PitchRound Company Presentation #1
10:15am - 10:30am — PitchRound Company Presentation #2
10:30am - 10:45pm — PitchRound Company Presentation #3
10:45am - 11:00m — Networking Break
11:00am - 11:15am — PitchRound Company Presentation #4
11:15am - 11:30am — PitchRound Company Presentation #5
11:30am - 12:15pm — Concurrent Session #5

Concurrent Session #5A:

InnovationPractices in Regulatory Strategies

Concurrent Session #5B:

The Intersection of Digital Health and MedTech Innovation

12:15pm - 1:30pm — Lunch Keynote: Dr. Billy Cohn, J&J/ PitchRound Winner Announced

PitchRounds Winner Announced

Plenary SpeakerDr. William E. “Billy” Cohn, Vice President, J&J Medical Devices Companies and Director of the Center for Device Innovation, Houston

Prior to joining Johnson & Johnson, Dr. Cohn was Director of the Center for Technology and Innovation and Director of the legendary Cullen Cardiovascular Research Laboratory at the Texas Heart Institute in Houston.  Billy is a noted cardiovascular surgeon and visionary serial inventor.  He is a Professor of Surgery at Baylor College of Medicine and an Adjunct Professor of Bioengineering at both Rice University and the University of Houston.  His major research interests have been focused on decreasing the invasiveness of medical procedures in a wide variety of fields.

Dr. Cohn has been intimately involved in the development of the continuous-flow, totally implantable, artificial heart.  In 2011, Dr. Cohn and Dr. O. H. Frazier successfully implanted the first pulseless total heart replacement device in a human patient.  Dr. Cohn has a passion for medical device development and has more than 90 US patents granted or pending for his medical innovations that have provided the core technology for six venture-backed medical start-ups.

His numerous awards include an honorary doctorate in science from Oberlin College, the Distinguished Scientist Award, given by the MacDonald Fund, and the Edison Award for excellence in human-centered design and innovation for the SentreHEART® Lariat®.  In 2000, Dr. Cohn was named the distinguished Inventor of the Year by the U.S. Intellectual Property Owners Association.  In 2014 he was named Outstanding Inventor of the Year by the Houston IPO.  In addition, in 2014 he received the Innovation award at ICI in Tel Aviv for inventing the TVA everLINQ system for percutaneous AV fistula creation and for founding TVA Medical.  In 2015, he was awarded a Lifetime Achievement Award for healthcare innovation by the Houston Technology Center.  Lastly, before joining J&J, he was a Venture Partner at Santé Ventures and was the Chief Medical Officer for BiVACOR USA and for Reliant Heart.

After obtaining an undergraduate degree in Biology and Chemistry from Oberlin College in Ohio, Billy went on to receive his Doctor of Medicine from the Baylor College of Medicine in Houston, Texas.  He then completed seven years of general surgical and cardiothoracic surgical training at the Baylor College of Medicine Affiliated Hospitals and a one-year cardiothoracic fellowship at Boston’s Beth Israel Hospital. After completion of his training, he stayed on as a staff Cardiothoracic surgeon at the Beth Israel Deaconess Medical Center and as a full-time faculty of Harvard Medical School for ten years before being recruited back to his hometown of Houston.

1:30pm — Conference Adjourned